Search research articles
Contact Us
Filters
Showing results (371-380 of 418) with videos related to
Page
of 42
Sort By:
The Journal of Antimicrobial Chemotherapy
|
December 10, 2021
Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
Ana Virseda-Berdices, Oscar Brochado-Kith, Cristina Díez, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Plasma miRNA-Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure
Ana Virseda-Berdices, Raquel Behar-Lagares, Juan Berenguer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 9, 2020
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Ana Carrero, Juan Berenguer, Víctor Hontañón, et al.
Journal of Infection and Public Health
|
December 28, 2025
Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance
Sergio Grande-García, Manuel Llamas-Adán, Celia Crespo-Bermejo, et al.
Frontiers in Immunology
|
January 22, 2026
Gender-based differences in telomere attrition and long-term respiratory dysfunction in COVID-19 ICU survivors one year post-infection: implications for aging-associated pulmonary decline
Raquel Behar-Lagares, Ana Virseda-Berdices, Óscar Martínez-González, et al.
Journal of Infection and Public Health
|
September 6, 2024
Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis
Oscar Brochado-Kith, Marta Rava, Juan Berenguer, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Long-Term Hemostatic and Endothelial Dysregulation Associated with Cardiovascular Events in Survivors of COVID-19 Previously Admitted to the ICU
Raquel Behar-Lagares, Ana Virseda-Berdices, Óscar Martínez-González, et al.
Frontiers in Immunology
|
February 18, 2026
HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis
Rubén Martín-Escolano, Amanda Fernández-Rodríguez, Laura Tarancon-Diez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 21, 2024
Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients
Ana Virseda-Berdices, Rubén Martín-Escolano, Juan Berenguer, et al.
International Journal of Health Services : Planning, Administration, Evaluation
|
April 29, 2021
Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study
Christian Ortega-Loubon, Gema Ruiz López Del Prado, María F Muñoz-Moreno, et al.
Page
of 42
Search research articles
Search
Showing results (371-380 of 418) with videos related to
Sort By:
Page
of 42
The Journal of Antimicrobial Chemotherapy
|
December 10, 2021
Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
Ana Virseda-Berdices, Oscar Brochado-Kith, Cristina Díez, et al.
Pharmaceuticals (Basel, Switzerland)
|
January 28, 2026
Plasma miRNA-Metabolite Dysregulation in People with HIV with Cirrhosis Despite Successful HCV Cure
Ana Virseda-Berdices, Raquel Behar-Lagares, Juan Berenguer, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 9, 2020
Effects of Eradication of HCV on Cardiovascular Risk and Preclinical Atherosclerosis in HIV/HCV-Coinfected Patients
Ana Carrero, Juan Berenguer, Víctor Hontañón, et al.
Journal of Infection and Public Health
|
December 28, 2025
Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance
Sergio Grande-García, Manuel Llamas-Adán, Celia Crespo-Bermejo, et al.
Frontiers in Immunology
|
January 22, 2026
Gender-based differences in telomere attrition and long-term respiratory dysfunction in COVID-19 ICU survivors one year post-infection: implications for aging-associated pulmonary decline
Raquel Behar-Lagares, Ana Virseda-Berdices, Óscar Martínez-González, et al.
Journal of Infection and Public Health
|
September 6, 2024
Altered blood microbiome in patients with HCV-related Child-Pugh class B cirrhosis
Oscar Brochado-Kith, Marta Rava, Juan Berenguer, et al.
International Journal of Molecular Sciences
|
July 29, 2025
Long-Term Hemostatic and Endothelial Dysregulation Associated with Cardiovascular Events in Survivors of COVID-19 Previously Admitted to the ICU
Raquel Behar-Lagares, Ana Virseda-Berdices, Óscar Martínez-González, et al.
Frontiers in Immunology
|
February 18, 2026
HIV status defines distinct immunological drivers of persistent portal hypertension after HCV cure in people with advanced cirrhosis
Rubén Martín-Escolano, Amanda Fernández-Rodríguez, Laura Tarancon-Diez, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 21, 2024
Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients
Ana Virseda-Berdices, Rubén Martín-Escolano, Juan Berenguer, et al.
International Journal of Health Services : Planning, Administration, Evaluation
|
April 29, 2021
Impact of the Economic Crisis on Endocarditis Mortality in Spain: A Nationwide Study
Christian Ortega-Loubon, Gema Ruiz López Del Prado, María F Muñoz-Moreno, et al.
Page
of 42